Cargando…

Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes

GPR120 is a promising target for the treatment of type 2 diabetes (T2DM), which is activated by free fatty acids (FFAs) and stimulates the release of glucagon-like peptide-1(GLP-1). GLP-1, as an incretin, can enhance glucose-dependent secretion of insulin from pancreatic beta cells and reduce blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Guoxia, Guo, Qinghua, Xue, Qidi, Kong, Ruifang, Wang, Shiben, Lei, Kang, Liu, Renmin, Wang, Xuekun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624523/ https://www.ncbi.nlm.nih.gov/pubmed/34833999 http://dx.doi.org/10.3390/molecules26226907

Ejemplares similares

Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes
por: Wang, Xuekun, et al.
Publicado: (2022)

Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus
por: Wang, Xuekun, et al.
Publicado: (2022)

Potential roles of GPR120 and its agonists in the management of diabetes
por: Zhang, Dan, et al.
Publicado: (2014)

Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron
por: Zhao, Xiaodi, et al.
Publicado: (2023)

Synthesis of 1,3,4-oxadiazoles derivatives with antidepressant activity and their binding to the 5-HT(1A) receptor
por: Wang, Shiben, et al.
Publicado: (2020)

A Gpr120 Selective Agonist Improves Insulin Resistance and Chronic Inflammation
por: Oh, Da Young, et al.
Publicado: (2014)

Fluorescent Ligand-Based Discovery of Small-Molecule Sulfonamide Agonists for GPR120
por: Ma, Siyue, et al.
Publicado: (2022)

GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery
por: Carullo, Gabriele, et al.
Publicado: (2021)

The GPR120 Agonist TUG-891 Inhibits the Motility and Phagocytosis of Mouse Alveolar Macrophages
por: Su, Xing-Li, et al.
Publicado: (2020)

GPR120 Agonist GW9508 Ameliorated Cellular Senescence Induced by ox-LDL
por: Liu, Ruijie, et al.
Publicado: (2020)

Identification and Semi-Synthesis of 3-O-Protocatechuoylceanothic Acid, a Novel and Natural GPR120 Agonist †
por: Lim, Changjin, et al.
Publicado: (2019)

Molecular docking and identification of G-protein-coupled receptor 120 (GPR120) agonists as SARS COVID-19 MPro inhibitors
por: Mohan, Sellappan, et al.
Publicado: (2022)

The GPR120 agonist TUG‐891 promotes metabolic health by stimulating mitochondrial respiration in brown fat
por: Schilperoort, Maaike, et al.
Publicado: (2018)

Development of Free Fatty Acid Receptor 4 (FFA4/GPR120) Agonists in Health Science
por: Son, So-Eun, et al.
Publicado: (2021)

Regulation of Energy Homeostasis via GPR120
por: Ichimura, Atsuhiko, et al.
Publicado: (2014)

Predictive value of first-trimester GPR120 levels in gestational diabetes mellitus
por: He, Qingwen, et al.
Publicado: (2023)

Design, Synthesis, and In Vivo and In Silico Evaluation of Coumarin Derivatives with Potential Antidepressant Effects
por: Wang, Xuekun, et al.
Publicado: (2021)

FFA4/GPR120: Pharmacology and Therapeutic Opportunities
por: Milligan, Graeme, et al.
Publicado: (2017)

GPR120 is an important inflammatory regulator in the development of osteoarthritis
por: Chen, Yuanfeng, et al.
Publicado: (2018)

GPR120 promotes neutrophil control of intestinal bacterial infection
por: Zhou, Zheng, et al.
Publicado: (2023)

Synthesis and Evaluation of Antidepressant Activities of 5-Aryl-4,5-dihydrotetrazolo [1,5-a]thieno[2,3-e]pyridine Derivatives
por: Wang, Shiben, et al.
Publicado: (2019)

Polyunsaturated fatty acid receptors, GPR40 and GPR120, are expressed in the hypothalamus and control energy homeostasis and inflammation
por: Dragano, Nathalia R. V., et al.
Publicado: (2017)

The Role of GPR120 Receptor in Essential Fatty Acids Metabolism in Schizophrenia
por: Rog, Joanna, et al.
Publicado: (2020)

GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice
por: Zhao, Jie, et al.
Publicado: (2016)

Protective role of GPR120 in the maintenance of pregnancy by promoting decidualization via regulation of glucose metabolism
por: Huang, Jiefang, et al.
Publicado: (2018)

GPR120 prevents colorectal adenocarcinoma progression by sustaining the mucosal barrier integrity
por: Rubbino, Federica, et al.
Publicado: (2022)

GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome
por: Qin, Zhangjin, et al.
Publicado: (2022)

GPR120: A bi-potential mediator to modulate the osteogenic and adipogenic differentiation of BMMSCs
por: Gao, Bo, et al.
Publicado: (2015)

Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases
por: Wannick, Melanie, et al.
Publicado: (2018)

Multiple tyrosine metabolites are GPR35 agonists
por: Deng, Huayun, et al.
Publicado: (2012)

DHA Protects Hepatocytes from Oxidative Injury through GPR120/ERK-Mediated Mitophagy
por: Chen, Jinglong, et al.
Publicado: (2021)

Label-Free Phenotypic Profiling Identified D-Luciferin as a GPR35 Agonist
por: Hu, Haibei, et al.
Publicado: (2012)

Genetic variants of the unsaturated fatty acid receptor GPR120 relating to obesity in dogs
por: MIYABE, Masahiro, et al.
Publicado: (2015)

EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4
por: Kamata, Ryo, et al.
Publicado: (2016)

A new insight into identification of in silico analysis of natural compounds targeting GPR120
por: Chinthakunta, Nagaraju, et al.
Publicado: (2018)

Revisiting PPARγ as a new friend of GPR120 in the treatment of metabolic disorders
por: Paschoal, Vivian A., et al.
Publicado: (2020)

Omega-3 from Flaxseed Oil Protects Obese Mice Against Diabetic Retinopathy Through GPR120 Receptor
por: Dátilo, Marcella Neves, et al.
Publicado: (2018)

Microbial biotransformation to obtain stilbene methylglucoside with GPR119 agonistic activity
por: Peng, Yu, et al.
Publicado: (2023)

Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis
por: Wang, Xue, et al.
Publicado: (2019)

Discovery of GPR183 Agonists Based on an Antagonist Scaffold
por: Kjær, Viktoria M. S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ea9t33mt0uv8r4frenk3a47nbh